Elastin degradation products (EDPs) have been associated with insulin resistance in preclinical studies, which is a property that can be reversed using the proteoglycan chondroitin sulfate, supporting a complex interplay between components of the ECM [41]. The gene discussed is ELN; the disease is Insulin resistance.